Using ketamine to help mothers with depression and pain after cesarean delivery
Ketamine to reduce postpartum depression and pain after cesarean delivery
This study is looking at how ketamine can help new moms feel better by reducing postpartum depression and pain after a cesarean delivery, and it aims to find the best dose to improve their mood and manage pain safely.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11086759 on NIH RePORTER |
What this research studies
This research investigates the use of ketamine to alleviate postpartum depression and pain in mothers who have undergone cesarean delivery. The study aims to determine the optimal dosage of ketamine and its effects on pain management and mood improvement in this specific population. By focusing on the unique challenges faced by new mothers, the research seeks to provide a more effective treatment option that considers both pain relief and mental health. Participants will be monitored for side effects and overall recovery to ensure the safety and efficacy of the treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are mothers who have recently undergone a cesarean delivery and are experiencing symptoms of postpartum depression or pain.
Not a fit: Patients who have not had a cesarean delivery or those who do not experience postpartum depression or pain may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new treatment option that significantly reduces postpartum depression and pain for mothers after cesarean delivery.
How similar studies have performed: While there have been limited studies on ketamine for postpartum conditions, this research aims to fill a significant knowledge gap and explore its effects specifically in postpartum women after cesarean delivery.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Lim, Grace — University of Pittsburgh at Pittsburgh
- Study coordinator: Lim, Grace
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.